unisa logo

Clive Prestige and students

Nanostructure and Drug Delivery

Our mission

The Nanostructure and Drug Delivery Group is focused on the use of pharmaceutical science and nanomedicine approaches to provide drug delivery solutions to challenging therapeutic molecules, and to advance new medicines in such fields as cancer chemotherapy drugs, anti-infective agents, anti-psychotics and cardiovascular drugs.

The Group’s primary mission is to:

  1. Engineer novel particle based biomaterials with specific biological activity and their application to solve biopharmaceutical challenges.
  2. Determine mechanisms for bioactivity through advanced colloidal, interfacial and biophysical analyses
  3. Develop drug delivery solutions to address unmet clinical needs.

Some of our major challenges are to:

  1. Deliver Challenging Therapeutic Molecules (both small molecular drugs and biologics) – For Better Medicines
  2. Eradicate Bacterial Biofilms
  3. Optimise Biotech and Pharmaceutical Formulation, Processing and Manufacture

The Nanostructure and Drug Delivery Group’s specific  research project areas include:

  • Particle based nano-biomaterials with specific biological activity and their application to solve biopharmaceutical challenges
  • Hybrid lipid-based oral drug delivery systems – mimicking the pharmaceutical food effect.
  • Nano-carriers for eradication of bacterial biofilms
  • Combination of prodrugs and nanomedicines for improved oral chemotherapy
  • Mechanisms of oral drug delivery

Our Researchers

Students

  • Tahnee Dening
  • Hayley Schultz
  • Tahlia Meola
  • Sajedehsadat Maghrebi
  • Yassamin Albayaty
  • Leah Wright
  • Chelsea Thorn
  • Kara Paxton
  • Santhni Subramaniam
  • Catalin Frydendal